BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-3	Closed	-$90	–	1932
2026 Q2	$90	Buy	+3	New	+$85	﹤0.01%	2358

Other funds holding LKFT

Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return

Prosight Management Dallas, Texas $515M AUM 2.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.'s LKFT Position: Q3 2026 in Review

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2026, closing a stake of 3 shares — an estimated $90 sold.

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. first reported a position in LKFT in Q2 2026 and held it in 1 quarter. The position peaked at $90 in Q2 2026. 67 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2026 after selling out during the quarter.
BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. sold 3 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2026, an estimated $90.
BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2026 and held it in 1 quarter.
BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.'s Lakefront Biotherapeutics American Depositary Shares position peaked at $90 in Q2 2026.
67 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.'s 13F filing for Q3 2026, filed 13 Nov 2026.